TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 180 filers reported holding TRANSMEDICS GROUP INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,134,990 | -42.4% | 93,790 | -11.6% | 0.20% | -39.9% |
| Q2 2023 | $8,908,528 | +67.8% | 106,080 | +51.3% | 0.34% | +63.2% |
| Q1 2023 | $5,307,637 | +1426.6% | 70,090 | +1144.3% | 0.21% | +1293.3% |
| Q4 2022 | $347,669 | +47.9% | 5,633 | -0.1% | 0.02% | +50.0% |
| Q3 2022 | $235,000 | – | 5,639 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
| Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
| Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
| Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
| Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
| Triumph Capital Management | 20,051 | $622,000 | 0.36% |
| EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
| Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |